 14 PM / Updated 7 minutes ago BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543 Reuters Staff 
Jan 12 (Reuters) - Concert Pharmaceuticals Inc: 
* FDA GRANTS FAST TRACK DESIGNATION TO CONCERT PHARMACEUTICALS’ CTP-543 FOR THE TREATMENT OF ALOPECIA AREATA 
* CONCERT PHARMA SAYS U.S. FDA GRANTED FAST TRACK DESIGNATION FOR CO‘S CTP-543 Source text for Eikon: Further company coverage: